Cargando…

Effects of psychotropic switches on weight change: a prospective cohort study

INTRODUCTION: Many psychotropic drugs can induce weight gain with differences in their metabolic risk profiles (i.e. high, medium or low-risk). OBJECTIVES: To compare the weight evolution of patients switching versus patients keeping their psychotropic drugs with different risk-profiles. METHODS: Da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piras, M., Ranjbar, S., Dubath, C., Laaboub, N., Grosu, C., Gamma, F., Von Plessen, K., Von Gunten, A., Conus, P., Eap, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567840/ http://dx.doi.org/10.1192/j.eurpsy.2022.1887

Ejemplares similares

DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
por: Dubath, C., et al.
Publicado: (2022)

Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort
por: Laaboub, N., et al.
Publicado: (2022)

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
por: Schoretsanitis, Georgios, et al.
Publicado: (2022)

Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study
por: Piras, Marianna, et al.
Publicado: (2023)

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis
por: Sjaarda, Jennifer, et al.
Publicado: (2023)

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort
por: Laaboub, Nermine, et al.
Publicado: (2021)

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients
por: Delacrétaz, Aurélie, et al.
Publicado: (2019)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
por: Lenski, Marie, et al.
Publicado: (2021)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Weight gain and metabolic disorders induced by psychotropic drugs: an appraisal of risk factors
por: Eap, C. B.
Publicado: (2023)

Clinical, genetic and environmental influences on weight gain and metabolic disorders induced by psychotropic drugs
por: Eap, C.
Publicado: (2022)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

F227. PSYCHOLOGICAL TRAUMA OCCURRING DURING ADOLESCENCE IS ASSOCIATED WITH AN INCREASED RISK OF GREATER WAIST CIRCUMFERENCE IN EARLY PSYCHOSIS PATIENTS INDEPENDENTLY OF MEDICATION
por: Alameda, Luis, et al.
Publicado: (2018)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication
por: Alameda, Luis, et al.
Publicado: (2020)

Glaucoma and Psychotropics
por: Cavaco, T., et al.
Publicado: (2022)

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
por: Perry, B., et al.
Publicado: (2022)

CYP2C19 expression modulates affective functioning and brain anatomy – a large single-center community-dwelling cohort study
por: Grosu, C., et al.
Publicado: (2022)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs
por: Eap, Chin B.
Publicado: (2016)

Specificities of the Use of Psychotropic Drugs in Bariatric Surgery
por: Fernandes Santos, C., et al.
Publicado: (2022)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

The interactions between COVID-19 drugs and psychotropic agents
por: Hiemke, C.
Publicado: (2021)

Sexual dysfunction induced by psychotropic drugs: a narrative review.
por: Álvarez, C.
Publicado: (2023)

Ischemic colitis induced by psychotropics drugs: a case report
por: Alvarez Garcia, C., et al.
Publicado: (2022)

Effects of psychotropic medications on pregnancy and breast feeding
por: LAD, ASHWINI, et al.
Publicado: (2022)

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

1498. Geographic differences in weight change on dolutegravir: a prospective cohort study
por: Chen, Geoffrey, et al.
Publicado: (2023)

Misuse of psychotropic medications among hospitalized patients
por: Azraf, F., et al.
Publicado: (2023)

Weight Gain, Obesity, and Psychotropic Prescribing
por: Nihalani, Nikhil, et al.
Publicado: (2011)

Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature
por: Dent, Robert, et al.
Publicado: (2012)

Psychotropic treatment in patients with arrhythmia: About a case
por: Suárez-Gómez, M., et al.
Publicado: (2021)

Sexual disorders and psychotropic drugs :about 250 cases
por: tbatou, L., et al.
Publicado: (2023)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
por: Ramírez González, J., et al.
Publicado: (2023)

Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
por: Henderson, Angela, et al.
Publicado: (2020)

Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
por: Yingyang, Zhang, et al.
Publicado: (2021)

Psychotropic drugs cross-reactivity with amphetamines in a FAERS sample: an international pharmacovigilance study
por: Giacovelli, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_su26nu17n5uvkjkg9uni231gsl